EHRA 2024: Late-Breaking Science Video Collection
Published: 22 April 2024
-
Views:
1267
-
Likes:
7
-
Views:
1267
-
Likes:
7
-
Up Next -
5m 26sPart 1 | Session 5 Non-Vitamin K Antagonist Oral Anticoagulant in AHRE Patients: NOAH -
6m 51sPart 1 | Session 6 Personalised PVI: The QDOT-by-LAWT Trial -
7m 10sPart 1 | Session 7 AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease
-
4m 54sPart 1 | Session 1 Venous Vascular Closure Vs Manual Compression: Style-AF Roland R Tilz
-
4m 3sPart 1 | Session 2 FIH Clinical Series of Conformable "Single Shot" PFA Catheter for PVI Vivek Reddy
-
8m 5sPart 1 | Session 3 Risk of Stroke or Embolism and AF: ARTESiA Substudy William McIntyre
Overview
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.
More from this programme
Part 1
Expert Interviews
Part 2
Highlights
About the episode
EHRA 24 - Investigator, Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, DE) is interviewed on ablation strategies for repeat procedures in patients with recurrent atrial fibrillation (AF).
The ASTRO trial is a multi-centre prospective randomized study that enrolled 256 patients with drug-refractory AF despite previous AF ablation. The trial showed no statistically significant differences between CB guided LAAI over LVA ablation in patients with AF despite durable PVI.
Interview Questions:
- What is the reasoning behind this study?
- What is the patient population and study design?
- What are the key findings revealed at EHRA 24?
- What are your key take-home messages?
- How should these findings change practice?
- What are the remaining questions?
Recorded on-site at EHRA in Berlin, 2024.
Support: This is an independent interview conducted by Radcliffe Cardiology.
Editors: Jordan Rance, Mirjam Boros
Video Specialists: Oliver Miles, Dan Brent
Faculty Biographies
Boris Schmidt
Dr Boris Schmidt is a Cardiologist specialising in Electrophysiology at Cardiologisches Centrum Bethanien in Frankfurt, Germany. Dr Boris Schmidt's scientific activities are focused on catheter ablation of atrial fibrillation and the development of novel single-shot technologies as well as interventional stroke prophylaxis.
Comments